Clinical Trial Detail

NCT ID NCT02728830
Title A Study of Pembrolizumab on the Tumoral Immunoprofile of Gynecologic Cancers
Recruitment Active, not recruiting
Gender female
Phase Phase I
Variant Requirements No
Sponsors Stephanie Gaillard, M.D.
Indications

fallopian tube cancer

peritoneum cancer

endometrial cancer

ovary epithelial cancer

Therapies

Pembrolizumab

Age Groups: adult

No variant requirements are available.